Main market
Access this stock data via API
Subscribe
BioInvent International AB
0
0
0%

Financials

Balance sheet

Fiscal date Jun 2025 Mar 2025 Dec 2024 Sep 2024
Total assets 916.7M 862.8M 989.2M 1.1B
Current assets 876.7M 819.1M 943.2M 1.0B
Cash 434.8M
Cash equivalents
Cash and cash equivalents 404.1M 475.3M 434.8M 717.4M
Other short term investments 393.5M 266.9M 432.3M 232.8M
Accounts receivable 69.3M 69.2M 8.3M 51.0M
Other receivables 23.0M
Inventory 9.9M 7.7M 11.0M 9.9M
Prepaid assets 33.8M
Restricted cash
Assets held for sale
Hedging assets
Other current assets
Non current assets 40.0M 43.7M 46.0M 76.5M
Properties 40.0M 43.7M 115.5M 47.4M
Land and improvements
Machinery furniture equipment
Construction in progress
Leases
Accumulated depreciation -86.0M
Goodwill 0 0 0 0
Investment properties
Financial assets
Intangible assets
Investments and advances
Other non current assets
Total liabilities 105.9M 93.1M 103.4M 84.4M
Current liabilities 102.1M 87.0M 95.2M 76.1M
Accounts payable 49.1M
Accrued expenses
Short term debt 9.1M 9.2M 9.2M 8.7M
Deferred revenue
Tax payable
Pensions
Other current liabilities 93.0M 77.9M 5.5M 67.4M
Non current liabilities 3.8M 6.0M 8.2M 8.3M
Long term provisions
Long term debt 3.8M 6.0M 8.2M 8.3M
Provision for risks and charges
Deferred liabilities
Derivative product liabilities
Other non current liabilities
Shareholders equity
Common stock 13.2M
Retained earnings -2.9B
Other shareholders equity
Total shareholders equity 810.7M 769.7M 885.8M 1.0B
Additional paid in capital 3.8B
Treasury stock
Minority interest
Access the full /balance_sheet historical dataset via the API — starting from the Pro plan.
Main market

Exchange is currently active.
Closing in 3 hours 5 minutes

14:24
00:00
09:00
17:30
23:59

Trading Hours (Monday - Friday):

Main market
09:00 - 17:30
All times are displayed in the Europe/Stockholm timezone (CET, UTC+01:00).